Groowe Groowe / Newsroom / JNJ
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

JNJ News

Johnson & Johnson

Johnson & Johnson to Participate in the Goldman Sachs 47 th Annual Global Healthcare Conference

businesswire.com
JNJ

AI Transforms Pharmaceutical Packaging as Industry Invests Billions in Zero-Defect Quality Control Systems

globenewswire.com
NVS PFE JNJ

Presbyopia Market to Witness Accelerated Growth at a CAGR of 4.9% During the Forecast Period (2026–2036) Supported by Expanding Treatment Landscape | DelveInsight

globenewswire.com
ABBV NVS ALC JNJ BHC

Talvey (Johnson & Johnson: talquetamab-tgvs) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
JNJ

FarmaMondo Group appoints Independent Board Director Natalie Douglas, global pharmaceutical managed access and commercialization pioneer USA - English USA - Français USA - Deutsch USA - español USA - English

prnewswire.com
JNJ

Le groupe FarmaMondo nomme Natalie Douglas, pionnière mondiale de l'accès géré aux produits pharmaceutiques et de leur commercialisation, comme administratrice indépendante USA - Français USA - Deutsch USA - English USA - español USA - English

prnewswire.com
JNJ

FarmaMondo Group appoints Independent Board Director Natalie Douglas, global pharmaceutical managed access and commercialization pioneer USA - English USA - English USA - Français USA - español USA - Deutsch

prnewswire.com
JNJ

Johnson & Johnson reinforces its leadership in advancing neuropsychiatry with new portfolio and pipeline data at APA and ASCP

prnewswire.com
JNJ

Global Medical Adhesives Market Forecast to 2031 by Technology, Resin Type, Application and Region

globenewswire.com
SOLV FUL JNJ

Neurovascular Devices Global Forecast Report 2025: A $7.22 Billion Opportunity by 2030, Driven by Advancement of AI- and Robot-Assisted Systems for Next-Generation Neurointerventions

globenewswire.com
SYK MDT JNJ TER PEN